Management of BPH causing BOO
6. Which of the following statements are true?except
A All patients with acute retention ultimately require prostatectomy.
B Chronic retention accounts for 15% of prostatectomies.
C Severe symptoms account for 60% of prostatectomies.
D Drug therapy is with α-blockers and/or 5α-reductase inhibitor.
E A low maximum flow rate of <10 mL/s and a residual volume of 100–250 mL are indications for surgery.
6. Which of the following statements are true?except
A All patients with acute retention ultimately require prostatectomy.
B Chronic retention accounts for 15% of prostatectomies.
C Severe symptoms account for 60% of prostatectomies.
D Drug therapy is with α-blockers and/or 5α-reductase inhibitor.
E A low maximum flow rate of <10 mL/s and a residual volume of 100–250 mL are indications for surgery.
Management of BPH causing BOO
6. Which of the following statements are true?except
A All patients with acute retention ultimately require prostatectomy.
B Chronic retention accounts for 15% of prostatectomies.
C Severe symptoms account for 60% of prostatectomies.
D Drug therapy is with α-blockers and/or 5α-reductase inhibitor.
E A low maximum flow rate of <10 mL/s and a residual volume of 100–250 mL are indications for surgery.
6. Which of the following statements are true?except
A All patients with acute retention ultimately require prostatectomy.
B Chronic retention accounts for 15% of prostatectomies.
C Severe symptoms account for 60% of prostatectomies.
D Drug therapy is with α-blockers and/or 5α-reductase inhibitor.
E A low maximum flow rate of <10 mL/s and a residual volume of 100–250 mL are indications for surgery.
This media is not supported in your browser
VIEW IN TELEGRAM
7. The following statements are true except:
A α-adrenergic blocking agents inhibit the contraction of prostatic smooth muscle. B 5α-reductase inhibitors inhibit the conversion of testosterone to DHT.
C Drug therapy results in 20% improvement in symptom scores.
D Transurethral resection of the prostate (TURP) results in 75% improvement in the symptom scores.
E Retrograde ejaculation occurs in all patients after TURP.
A α-adrenergic blocking agents inhibit the contraction of prostatic smooth muscle. B 5α-reductase inhibitors inhibit the conversion of testosterone to DHT.
C Drug therapy results in 20% improvement in symptom scores.
D Transurethral resection of the prostate (TURP) results in 75% improvement in the symptom scores.
E Retrograde ejaculation occurs in all patients after TURP.
Carcinoma of the prostate
Which of the following statements are true in carcinoma of the prostate?except
A It is the most common cancer in men over the age of 65 years.
B In the younger age group who develop prostate cancer, 10%–15% have a positive family history.
C A patient who has had a prostatectomy for BPH can develop prostate cancer. D Carcinoma mostly originates in the peripheral zone of the prostate.
E Prostate-specific antigen (PSA) is an extremely reliable method of screening
Which of the following statements are true in carcinoma of the prostate?except
A It is the most common cancer in men over the age of 65 years.
B In the younger age group who develop prostate cancer, 10%–15% have a positive family history.
C A patient who has had a prostatectomy for BPH can develop prostate cancer. D Carcinoma mostly originates in the peripheral zone of the prostate.
E Prostate-specific antigen (PSA) is an extremely reliable method of screening
9. The following statements are true except:
A The histological type is an adenocarcinoma.
B Gleason scoring system is based on the degree of glandular differentiation.
C The Gleason score correlates well with spread and prognosis.
D Prostate is the most common site of origin for skeletal metastasis.
E Skeletal metastases from prostate cancer are mostly osteolytic.
A The histological type is an adenocarcinoma.
B Gleason scoring system is based on the degree of glandular differentiation.
C The Gleason score correlates well with spread and prognosis.
D Prostate is the most common site of origin for skeletal metastasis.
E Skeletal metastases from prostate cancer are mostly osteolytic.